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Trypanosoma cruzi, the agent of Chagas disease, binds to diverse extracellular matrix proteins. Such an ability prevails in the
parasite forms that circulate in the bloodstream and contributes to host cell invasion.Whether this also applies to the insect-
stage metacyclic trypomastigotes, the developmental forms that initiate infection in the mammalian host, is not clear. Using T.
cruzi CL strain metacyclic forms, we investigated whether fibronectin bound to the parasites and affected target cell invasion.
Fibronectin present in cell culture medium bound to metacyclic forms and was digested by cruzipain, the major T. cruzi cysteine
proteinase. G strain, with negligible cruzipain activity, displayed a minimal fibronectin-degrading effect. Binding to fibronectin
was mediated by gp82, the metacyclic stage-specific surface molecule implicated in parasite internalization. When exogenous
fibronectin was present at concentrations higher than cruzipain can properly digest, or fibronectin expression was stimulated by
treatment of epithelial HeLa cells with transforming growth factor beta, the parasite invasion was reduced. Treatment of HeLa
cells with purified recombinant cruzipain increased parasite internalization, whereas the treatment of parasites with cysteine
proteinase inhibitor had the opposite effect. Metacyclic trypomastigote entry into HeLa cells was not affected by anti-1 integrin
antibody but was inhibited by anti-fibronectin antibody. Overall, our results have indicated that the cysteine proteinase of T.
cruzimetacyclic forms, through its fibronectin-degrading activity, is implicated in host cell invasion.
Extracellular matrix (ECM) proteins, which serve as substratesfor diverse adhesion molecules and are involved in many im-
portant physiological processes, also maymediate cell attachment
and/or invasion of pathogenic microorganisms. Among these
molecules, fibronectin (FN) has been reported to play a role in
adherence to and invasion of host cells by bacteria such as Staph-
ylococcus aureus, Streptococcus pyogenes, and Campylobacter jejuni
(1–6). The interaction of fibronectin with Trypanosoma cruzi, the
protozoan parasite that causes Chagas disease, also has been de-
scribed.T. cruzi infection is initiated bymetacyclic trypomastigote
(MT) from the insect vector. This parasite form is responsible for
the initial T. cruzi-host cell interaction upon entering the mam-
malian host through the skin or by the oral route. Following MT
internalization in a membrane-bound vacuole and escape to the
cytoplasm, the parasite differentiates into amastigote form. After
several rounds of replication, amastigotes transform into trypo-
mastigotes that are released in the circulation upon host cell rup-
ture. Experiments with tissue culture trypomastigote (TCT),
which corresponds to the bloodstream trypomastigote, revealed
the involvement of fibronectin in target cell adhesion/invasion.
The treatment of 3T3fibroblasts or rat peritonealmacrophages, or
TCT, with human plasma FN increased parasite-cell association
(7), and binding to the TCT surface of the peptide RGDS, corre-
sponding to the FN cell attachment site, inhibited parasite inter-
nalization (8). An 85-kDa protein from TCT was identified as the
ligand for FN (9). Inmurinemacrophages or humanbloodmono-
cytes, the uptake of amastigotes increased in the presence of exog-
enous FNor by pretreatment of either parasite or host cell with FN
(10). There is no information on whether FN is required for MT
internalization. As different T. cruzi developmental forms may
differentially interact with ECM components, we investigated the
participation of FN inMTentry into human epithelial cells, as well
as the FN-binding property of gp82, the metacyclic-stage surface
molecule implicated in T. cruzi infection in vitro as well as in vivo
(11–13). Gp82 is an adhesionmolecule that binds to host cells in a
receptor-mediated manner and promotes MT internalization
(11). Previous studies have shown that the ability of MT gp82 in
binding ECM components, such as collagen, heparan sulfate, and
laminin, is either null or very low (11, 14), in contrast to 80- to
85-kDa glycoproteins expressed in TCT that bind to these com-
pounds (15, 16). We also examined the role played in MT inter-
nalization by cruzipain, themajorT. cruzi cysteine proteinase that
is a member of a large family of closely related isoforms (17, 18).
Cruzipain has been implicated in host cell invasion by TCT (19)
through its activity on kininogen and bradykinin release (20),
which is increased up to 35-fold in the presence of heparan sulfate
(21). Using metacyclic forms of a T. cruzi strain that enter target
cells in a manner mediated by gp82, in this study we tested the
possibility that cruzipain interacted with fibronectin and modu-
lated the T. cruzi invasion of host cells.
MATERIALS AND METHODS
Parasites, mammalian cells, and cell invasion assay. T. cruzi strain CL
(22) was used throughout. In some experiments, G strain (23) also was
used. Parasites were maintained by cyclic passage in mice and in axenic
cultures in liver infusion tryptose medium. Metacyclic forms, at the sta-
tionary growth phase in liver infusion tryptose medium (G strain) or in
Grace’s medium (CL strain), were purified by passage through a DEAE-
cellulose column (24). HeLa cells, the human carcinoma-derived epithe-
Received 7 May 2014 Returned for modification 16 June 2014
Accepted 21 September 2014
Published ahead of print 29 September 2014
Editor: J. H. Adams
Address correspondence to Nobuko Yoshida, nyoshida@unifesp.br.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.
doi:10.1128/IAI.02022-14
5166 iai.asm.org Infection and Immunity p. 5166–5174 December 2014 Volume 82 Number 12
lial cells, were grown at 37°C in Dulbecco’s minimum essential medium
(DMEM) supplemented with 10% fetal bovine serum (FBS), streptomy-
cin (100 g/ml), and penicillin (100 U/ml) in a humidified 5% CO2 at-
mosphere. Cell invasion assays were carried out as previously described
(25) by incubating parasites with HeLa cells for 1 h at a multiplicity of
infection of 10:1 (CL strain) or 20:1 (G strain), either in serum-containing
DMEM, bovine serum albumin (BSA)-containing DMEM, or PBS
(PBS containing, per liter, 140 mg CaCl2, 400 mg KCl, 100 mg MgCl2 ·
6H2O, 100 mg MgSO4 · 7H2O, 350 mg NaHCO3). For intracellular para-
site counting, HeLa cells were washed in PBS, fixed in Bouin solution,
stained with Giemsa, and sequentially dehydrated in acetone, a graded
series of acetone-xylol and xylol. A total of 250 stained cells were counted.
Indirect immunofluorescence assay for visualization of fibronectin
inmammalian cells and in parasites.HeLa cells and A549 cells, grown in
13-mm glass slides, were incubated for 1 h at 4°C with polyclonal anti-
human FN antibody produced in rabbit and diluted 1:100 in PGN (0.15%
gelatin in PBS containing 0.1% sodium azide). Following washings in
PBS, 30min of fixation with 4% paraformaldehyde in PBS, and treatment
with 50mMNH4CL for 30min, the cells were incubated for 1 hwithAlexa
Fluor 568-conjugated anti-rabbit-IgG (Invitrogen) in PGN. After 1 h of
incubationwith phalloidin-fluorescein isothiocyanate (FITC; Invitrogen)
diluted 1:2,000 in PGN containing 0.1% saponin and 10 g/ml DAPI
(4=,6=1-diamino-2-phenylindole dihydrochloride) for visualization of ac-
tin cytoskeleton and nucleus, respectively, the cells were examined in a
confocal laser scanning microscope (Leica TCS SP8; Germany) equipped
with a Plan-Apochromat 63 objective (numerical aperture, 1.4) under
oil immersion. The z-series images were processed and analyzed using
Leica LAS AF software (2012 version; Leica, Germany). For the visualiza-
tion of FN on the parasite surface, purified metacyclic forms were incu-
bated for 1 h at 37°C in DMEM containing 10% FBS (DMEM-FBS). After
washings in PBS, anti-FN antibodies (Sigma-Aldrich), diluted 1:100 in
PGN, were added, and the incubation proceeded for 1 h at room temper-
ature. Followings washings in PBS, 30 min of fixation with 4% parafor-
maldehyde in PBS, and 30 min of treatment with 50 mM NH4CL, the
parasites were washed in PBS, placed onto glass slides, and dried. Upon 1
h of incubation with Alexa Fluor 488-conjugated anti-IgG (Invitrogen)
diluted in PGN containing 0.1% saponin and 10 g/ml DAPI for visual-
ization of kinetoplast and nucleus, images were acquired with a Nikon
E600 fluorescence microscope coupled to a Nikon DXM 1200F digital
camera using ACT-1 software. For the detection of the T. cruzi surface
molecule gp82, metacyclic forms were incubated for 1 h on ice with
monoclonal antibody directed to gp82. After washings in PBS and fixation
with 4% paraformaldehyde, the parasites were processed as described
above for visualization with the fluorescence microscope.
Fluorescence-activated cell sorting (FACS) analysis of T. cruzi MT
treated with E-64. Live metacyclic trypomastigotes (1  107) were left
untreated or were incubated with 100 M cysteine proteinase inhibitor
E-64 in PBS for 30 min at 37°C. After washings in PBS, E-64-treated
parasites were maintained for 1 h at 37°C in DMEM-FBS in the presence
of E-64, and the controls were maintained in the absence of inhibitor.
Thereafter, the parasites were fixed with 4% paraformaldehyde for 20
min. Followingwashings in PBS, the parasites were sequentially incubated
for 1 h at room temperature with anti-FN antibodies and Alexa Fluor
488-conjugated anti-IgG, and the number of fluorescence parasites was
estimated with a BD Accuri C6 flow cytometer.
Production and purification of recombinant cruzipain and gp82.
The recombinant protein based on T. cruzimajor cysteine protease (cru-
zipain), expressed in Escherichia coliDH5 without the COOH terminal,
was purified, and its activity was tested by fluorometric assay as described
previously (17). The production and purification of the recombinant
gp82 protein, containing the full-lengthT. cruzi gp82 sequence (GenBank
accession number L14824) in framewith glutathione S-transferase (GST),
were performed as detailed previously (26).
Binding of recombinant protein gp82 to FN. Microtiter plates were
coated with fibronectin (Sigma-Aldrich) at 2g/well. After blocking with
PBS containing 2 mg/ml bovine serum albumin (PBS-BSA) for 1 h at
37°C, the plates were sequentially incubated for 1 h with the recombinant
gp82 and the polyclonal monospecific antibody directed to gp82, pro-
duced by immunizing mice with the recombinant protein, all diluted in
PBS-BSA. Upon reaction with peroxidase-conjugated anti-mouse IgG in
PBS-BSA, the final reaction was revealed by o-phenilenediamine and the
absorbance at 492 nm read in a Multiscan MS enzyme-linked immu-
nosorbent assay (ELISA) reader.
Treatment of FN with recombinant cruzipain or with T. cruzi me-
tacyclic forms. Fibronectin was treated for 1 h at 37°C with 170 nM
recombinant cruzipain in 50 mM Na2PO4, 100 mM NaCl, 5 mM EDTA,
pH 6.5, 2.5 mM dithiothreitol (DTT), and 5% dimethyl sulfoxide
(DMSO). The control FN sample was incubated under the same condi-
tions in the absence of enzyme, and the sampleswere analyzed by the silver
staining of SDS-PAGE gel. The effect of T. cruzi on FN was examined by
incubating FNwith 3107metacyclic trypomastigotes in l00mMsodium
citrate, pH 6.5. After centrifugation, the pellet was discarded and the su-
pernatant was analyzed, along with the control FN, by SDS-PAGE and
Coomassie blue staining of the gel.
Determination of T. cruzi cysteine proteinase activity. Metacyclic
forms were lysed in 0.4% Triton X-100, solubilized in a sample buffer
without 2-mercaptoethanol, and then loaded onto 10% SDS-polyacryl-
amide gel copolymerized with 0.1% gelatin as the substrate. After electro-
phoresis, the gel was subjected to two 30-min washings with 2.5% Triton
X-100 in acetate buffer, pH6.0, to remove SDS and incubated overnight in
the same buffer without detergent. The gel was stained with Coomassie
blue R250 and destained for visualization of white bands against a blue
background.
Statistical analysis. The significance level of experimental data was
calculated using the Student t test, as implemented in the programGraph-
Pad Prism.
RESULTS
FN inhibits T. cruziMT entry into host cells.We first examined
whether FN was present on the surface of HeLa cells. By indirect
immunofluorescence microscopy, a positive reaction with an-
ti-FN antibodies was observed in human alveolar epithelial A549
cells but not in HeLa cells (Fig. 1A), confirming reports that FN is
undetectable onHeLa cell surfaces (27) or that it binds severalfold
less to HeLa cells than to fibroblasticMRC-5 cells (28). According
to another study, HeLa cells do not synthesize fibronectin and
form focal contacts in FN-depleted medium (29). To determine
whether FNwas required forMT entry intoHeLa cells, the follow-
ing sets of experiments were performed. CL strain metacyclic
forms were incubated with HeLa cells in DMEM containing 10%
FBS (DMEM-FBS) or in serum-free DMEM supplemented with
1% BSA (DMEM-BSA). FN was estimated to be present in
DMEM-FBS at approximately 3g/ml on the basis of a report that
FN concentration in FBS is 25 to 30 g/ml (30). After 1 h of
incubation, the number of intracellular parasites was counted.
MT internalization was lower in DMEM-FBS than in DMEM-
BSA, but the difference was not statistically significant (Fig. 1B).
This indicated that FN is not required for MT invasion. The next
experiment consisted of incubating MT with HeLa cells for 1 h in
DMEM-FBS that had been left unsupplemented or supplemented
with 40 g/ml bovine FN. Supplementation with FN significantly
diminished parasite invasion (Fig. 1C). In these assays, human FN
exhibited an inhibitory effect similar to that of bovine FN and was
preferentially used in subsequent experiments. FN concentrations
lower than 40g/ml were equally effective in inhibitingMT entry
into HeLa cells in DMEM-BSA (Fig. 1D). Other extracellular ma-
trix components, such as laminin and collagen, at 40 g/ml, had
no inhibitory effect. To further assess the effect of FN on MT
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invasion, assays also were performed with HeLa cells treated with
transforming growth factor beta (TGF-). Treatment of primary
cultures and established cell lines from various types with TGF-
stimulates the expression of fibronectin and collagen, as well as
their incorporation into the extracellular matrix (31). HeLa cells
were left untreated or were treated for 24 h with 20 ng/ml TGF-
and then were processed for immunofluorescence using anti-FN
antibodies. Confocal microscopy images showed that TGF- in-
duced FN expression in HeLa cells (Fig. 1E). Invasion assays with
HeLa cells treatedwithTGF-were performedwithMTofCL and
G strains. Human alveolar epithelial A549 cells also were tested.
Parasites were incubated for 1 h with untreated or TGF--treated
HeLa cells, or with A549 cells, in fibronectin-free PBS solution,
and the rate of invasion as well as the levels of parasite adhesion
were measured. Through Giemsa staining followed by sequential
dehydration, internalized parasites were discriminated from those
FIG 1 Inhibitory effect of fibronectin (FN) on T. cruzi MT entry into host cells. (A) Semiconfluent monolayers of HeLa and A549 cells were processed for
confocal fluorescence analysis using anti-FN antibodies andAlexa Fluor 568-conjugated anti-rabbit IgG (red), phalloidin-FITC (green) for F-actin visualization,
and DAPI (blue) for DNA. Bar, 10 m. Note the lack of FN expression in HeLa cells. (B) Metacyclic forms (CL strain) were incubated for 1 h with HeLa cells in
DMEM containing either 10% FBS (DMEM-FBS) or 1% BSA (DMEM-BSA), and the number of internalized parasites was counted in 250 Giemsa-stained cells.
Values are the means standard deviations (SD) from four independent assays. (C and D) MT invasion assays were performed in DMEM-FBS in the absence
or presence of 40g/ml bovine FN (C) or in DMEM-BSA containing human FN at the indicated concentrations (D). Values in panels C and D are the means
SD from three independent assays. The inhibition ofMT invasion by FNwas significant in panels C (*, P 0.005) andD (*, P 0.05; **, P 0.01; ***P 0.005).
(E) HeLa cells were either left untreated or treated with TGF- for 24 h and processed as described for panel A). Note the FN expression in TGF--treated cells.
(F) Untreated and TGF--treated HeLa cells, as well as A549 cells, were incubated withMT of the indicated T. cruzi strains. After 1 h, the number of internalized
and adherent parasites was counted in a total of 250 cells after Giemsa staining and sequential dehydration. The values are the means  SD from three
independent assays performed in duplicate. Values are the means SD from three independent assays. TGF- treatment significantly reduced MT internaliza-
tion (*, P 0.01). The difference in invasion rate betweenHeLa and A549 cells was significant (**, P 0.005). Shown on the right are Giemsa-stainedHeLa cells
with internalized metacyclic forms surrounded by a clear space (black arrows), clearly distinguishable from adherent parasites (red arrow). Scale bar, 10 m.
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merely adherent to cells (Fig. 1F). HeLa cells treated with TGF-
were significantly more resistant to invasion by MT of both
strains, and the ratio of adherent to internalized parasites was
much higher than that in untreated controls (Fig. 1F). The suscep-
tibility to invasion of A549 cells was comparable to that of TGF-
-treated HeLa cells (Fig. 1F). Taken together, these results indi-
cated that FN functions as a barrier forMT-target cell interaction.
MTsurfacemolecule gp82binds toFN.Metacyclic formsofT.
cruziCL strain used in this study engage the surfacemolecule gp82
to efficiently enter host cells (11). Therefore, binding of gp82 to
FN before interaction with target cells could impair parasite inter-
nalization. To determine whether gp82 binds to FN, ELISA was
performed by incubating FN-coated plates for 1 hwith the recom-
binant protein containing gp82 sequence fused to GST, or with
GST as a control, at various concentrations, followed by reaction
with antibodies directed to the recombinant gp82. These antibod-
ies that also recognized GST revealed that the recombinant gp82,
but not GST, binds to FN in a dose-dependent and saturableman-
ner (Fig. 2A). To examine the possibility that the FN-binding site
was nested in the gp82 central domain, where the host cell adhe-
sion sites are located (32), the GST-fused construct containing the
entire gp82 sequence and its counterpart lacking the central do-
main, which are schematically depicted in Fig. 2B, were used for
FN- and host cell-binding assays.Microtiter plates coatedwith FN
or with HeLa cells were incubated with either recombinant pro-
tein at 10 g/ml, and binding was revealed using polyclonal anti-
gp82 antibodies that react equally with both proteins. In repeated
experiments, the recombinant protein lacking the central domain
exhibited negligible adhesion capacity toward HeLa cells while
preserving the FN-binding property (Fig. 2C). Although the bind-
ing of the truncated construct to FN apparently was less efficient
than that of the full-length gp82 construct, the difference was not
statistically significant. An additional experiment confirmed that
the FN-binding site of gp82 is not nested in the central domain of
the molecule. Inhibition binding assays, performed by incubating
FN-coated plates with the recombinant gp82 in the presence of
individual 20-mer synthetic peptides with an overlap of 10 resi-
dues, spanning the gp82 central domain (32), revealed that none
of the 10 peptides tested was capable of significantly inhibiting
gp82 binding to FN (data not shown).
FN-degrading capacityofmetacyclic forms is associatedwith
cruzipain activity. To certify that FN from cell culture medium
binds to the MT surface, the parasites were incubated for 1 h in
DMEM-FBS and subsequently processed for immunofluores-
cence using anti-FN antibodies. In this assay, we also used a T.
cruzi strain (G) from the wild transmission cycle (23) that was
genetically divergent from theCL strain (33). FNwas undetectable
in the CL strain but could be visualized on the G strainMT surface
(Fig. 3A). Provided that FN binding is mediated by gp82 and the
gp82 molecules expressed in CL and G strains share 97.9% se-
quence identity (34), what could explain the observed difference?
Unequal gp82 distribution on the surface was unlikely. By immu-
nofluorescence, using monoclonal antibody directed to gp82,
both parasite strains displayed a similar profile of reactivity (Fig.
3A). We examined the possibility that CL strain MT digested FN
and that cruzipain was involved in the process. CL strain metacy-
clic forms express cruzipain, which is inhibited by the cysteine
proteinase inhibitor E-64 (35). To determine whether E-64 im-
paired the dissociation of FN fromMT, the parasites were treated
for 30 min with E-64 before incubation with DMEM-FBS. After 1
h in the culture medium, the untreated control and E-64-treated
parasites were processed for FACS analysis using anti-FN anti-
bodies. As shown in Fig. 3B, association with FN increased in
E-64-treated parasites. The same procedure used to analyze G
strain MT did not reveal any difference of reactivity to anti-FN
antibodies between untreated and E-64-treated parasites (Fig.
3B). The possibility that cruzipain is implicated in promoting
the dissociation of FN from CL strain MT was reinforced by
FIG 2 Binding ofT. cruzi gp82 to FN. (A) The recombinant gp82 protein, containing the full-length gp82 peptide sequence, was added tomicrotiter plates coated
with FN at the indicated concentrations, and the binding was assayed as described inMaterials andMethods. The reaction was revealed by sequential incubation
with polyclonal antibodies directed to the recombinant gp82, which reacted equally with the recombinant gp82 andGST (inset), and anti-mouse IgG conjugated
to peroxidase. Values are themeans SD from triplicates of one representative assay out of three. Note the FB binding of gp82 but not of GST. Shown in the inset
is the equal binding of the recombinant gp82 and GST (10 g/ml) to anti-gp82 antibody. OD, optical density. (B) Schematic representation of recombinant
proteins based on gp82 molecule. Shown are the GST-fused constructs containing the full-length gp82 sequence or lacking the central domain of the molecule,
where the cell adhesion sites are located. (C) Microtiter plates coated with FN or with HeLa cells were incubated with the indicated recombinant protein, at 10
g/ml, and the reaction proceeded as described for panel A. Values are the means  SD from three experiments performed in triplicate. The binding of gp82
protein lacking the central domain was significantly reduced (*, P 0.001) compared to that of full-length gp82.
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analyzing the cysteine proteinase activity of CL and G strains.
Electrophoresis of parasite extracts in gelatin-containing SDS-
PAGE gel, followed by Coomassie blue staining, revealed in CL
strain, but not in G strain, bands of 57 and 51 kDa correspond-
ing to cruzipain (Fig. 3C). To confirm the identity of these
bands as cruzipain, gel strips were left untreated or were treated
with E-64 or with the metalloproteinase inhibitor o-phenan-
throline. No proteinase activity was detected in the gel strip
treated with E-64, whereas the gel strip treated with o-phenan-
throline revealed bands indistinguishable from those in the
untreated control (Fig. 3D). It should be mentioned that the
lack of detection of G strain cruzipain activity in gelatin gel
presumably is not due to deficient expression but rather to the
inhibitory effect of chagasin bound to cruzipain. According to
FIG 3 Fibronectin-degrading activity of T. cruzi cysteine proteinase. (A) Metacyclic forms of the indicated strains were incubated for 1 h in DMEM-FBS and
processed for immunofluorescence using anti-FN antibodies or the monoclonal antibody directed to gp82, followed by anti-mouse IgG conjugated to Alexa
Fluor 488 (green) and DAPI (blue). Phase-contrast and immunofluorescence images of MT are shown. Bar, 5 m. (B) Metacyclic forms were incubated for 1 h
in DMEM-FBS in the absence (control) or in the presence of the cysteine proteinase inhibitor E-64. Subsequently, the parasites were processed for FACS analysis
using anti-FN antibodies. (C) To detect cruzipain activity, Triton X-100 extracts, equivalent to 2 107MT of the indicatedT. cruzi strains, were electrophoresed
in 10% SDS-PAGE gel containing gelatin and processed as described inMaterials andMethods. Note the lack of activity in G strain. (D) After electrophoresis, gel
strips were either left untreated or were treated with 1 ME-64 or with 10 mMmetalloproteinase inhibitor o-phenanthroline. Proteinase activity, undetectable
in the gel strip treated with E-64, was preserved after treatment with o-phenanthroline. (E) Human FN (30 ng) was incubated in the absence or in the presence
of 170 nM recombinant cruzipain (Cz) for 1 h at 37°C. The samples were subjected to SDS-PAGE, and the gel was silver stained. (F) Human FN (500 ng) was
incubated withMT for 1 h. After centrifugation, the pellet was discarded and the supernatant was analyzed by SDS-PAGE and staining of the gel with Coomassie
R250, along with the control FN and Cz-treated FN. (G) FN (1 g) was incubated for 1 h with CL or G strain MT in the absence or in the presence of E-64 and
processed as described for panel F. (H) Samples of CL strainMT alone ormixed with G strainMT at a ratio of 1:1, 1:9, or 9:1 were maintained for 30min at 37°C
in DTT-containing solution, pH 6.5. FN (1g) was added, and incubation proceeded for 1 h before analysis by SDS-PAGE, followed by silver staining of the gel.
Note the extensive inhibition of FN degradation at a CL/G ratio of 1:9.
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Santos et al. (36), the molar ratio of cruzipain and chagasin in
G strain (5:1) differs from that of several other T. cruzi strains
(	50:1).
To ascertain that cruzipain possessed FN-degrading activity, 1
g fibronectin was incubated in DTT-containing solution, pH
6.5, either alone orwith recombinant cruzipain that was untreated
or pretreated with E-64. After 1 h at 37°C, the samples were sub-
jected to SDS-PAGE and the gel was silver stained. FN was exten-
sively degraded by cruzipain in amanner inhibitable by E-64 (Fig.
3E). The FN-digesting activity of MT was ascertained by incubat-
ing 3 107 parasites (CL strain) with 500 ng FN in sodium citrate,
pH 6.5. After centrifugation, the pellet was discarded and the su-
pernatant was analyzed by SDS-PAGE and staining of the gel with
Coomassie R250 along with the control FN and cruzipain-treated
FN. Metacyclic forms were capable of degrading FN in the same
manner as the recombinant cruzipain (Fig. 3F). To further assess
the association of cruzipainwith the FN-degrading activity ofMT,
the cruzipain-deficient G strain also was examined by incubating
3  107 parasites with 1 g FN by following the procedure de-
scribed above. Metacyclic forms of the CL strain, but not of the G
strain, extensively degraded FN in a manner inhibitable by E-64
(Fig. 3G). FN, ranging from 2 to 8 g, exhibited increasing resis-
tance but still was susceptible to degradation by CL strain MT
(data not shown). An additional experiment was performed to
investigate whether the FN-degrading activity of CL strain could
be affected by G strain. Samples of 3 107 CL strain MT alone or
mixed with G strain MT at a ratio of 1:1, 1:9, or 9:1 were main-
tained for 30min at 37°C inDTT-containing solution, pH 6.5. FN
(1 g) was added, and incubation proceeded for 1 h before anal-
ysis by SDS-PAGE followed by silver staining of the gel. Inhibition
of FN degradation was minimal at a CL-to-G ratio of 9:1, consid-
erable at 1:1, and very pronounced at 1:9 (Fig. 3H), suggesting that
this inhibitory effect is due to chagasin secreted by G strain.
Cruzipain is involved in CL strainMT invasion of host cells.
We assumed that the FN-digesting activity of cruzipain facilitated
MT invasion. To confirm that assumption, we tested the effect of
Z-(S-Bzl)Cys-Phe-CNH2, an irreversible inhibitor of cysteine
proteinase that was previously shown to impair TCT entry into
heart muscle cells (19). CL strain metacyclic forms were treated
for 15 min with this inhibitor at 10 M in PBS (diluted from a
stock solution at 200 mM in DMSO) or with DMSO at a 1:20,000
dilution in PBS as a control and then incubated for 1 h with HeLa
cells. Treatment with the inhibitor significantly reducedMT inva-
sion (Fig. 4A). In a parallel experiment, HeLa cells cultured in
DMEM-FBSwere treated with 170 nM recombinant cruzipain for
1 h, and after washing in PBS, the untreated and cruzipain-treated
cells were incubated with MT for 1 h in serum-free DMEM-BSA
medium. The cell susceptibility to MT invasion increased signifi-
cantly upon cruzipain treatment (Fig. 4B). To check whether
binding of gp82 to HeLa cells was altered after treatment with
cruzipain, untreated and cruzipain-treated cells were tested for
the binding of recombinant gp82. No difference in gp82 binding
was observed between untreated and cruzipain-treated cells (data
not shown). Invasion assays also were performed in which un-
treated and cruzipain-treated cells were incubated for 1 with me-
tacyclic forms that were untreated or were pretreated with anti-
gp82 monoclonal antibody, and the number of internalized
parasites was counted. MT entry into untreated and cruzipain-
treated cells was inhibited similarly by anti-gp82 antibody (Fig.
4C). These data indicate that, at least as far as the gp82 receptor is
concerned, HeLa cells were not greatly affected by cruzipain ac-
tion.
Integrin is not implicated in CL strain MT invasion of host
cells. The 1 family of integrins includes receptors for extracellu-
lar matrix ligands, and fibronectin is among them. The involve-
ment of 1 integrin in bacterial and viral internalization has been
demonstrated using antibody specific for 1 integrin (3, 4, 37).
FN-dependent S. aureus invasion of different cell types is medi-
ated by integrin 51 (3, 4), and either FN antiserum or mono-
clonal antibody specific for1 integrins dramatically reduces bac-
terial invasion (2). In the case of T. cruzi MT invasion that
apparently is FN independent, 1 integrin would not be impli-
cated. To check the validity of that assumption, we performed
experiments in whichHeLa cells in DMEM-FBSwere treated with
anti-FN or anti-1 integrin antibodies for 15min, and then, with-
out washing, metacyclic forms were added and incubations pro-
ceeded for 1 h before processing for intracellular parasite count-
ing. MT invasion was not inhibited by anti-1 integrin antibodies
but was significantly inhibited by anti-FN antibodies (Fig. 5A). In
an attempt to understand whyMT invasion is affected by anti-FN
antibodies, the following experiments were performed. Metacy-
clic forms (3  107) were incubated for 1 h with 2 g FN in the
absence or presence of anti-FN antibody. After centrifugation, the
supernatant was collected and analyzed by immunoblotting using
anti-FN antibodies. As in previous assays (Fig. 3F and G), FN was
extensively degraded upon incubation with MT, but anti-FN an-
tibody inhibited the process (Fig. 5B). To test the possibility that
anti-FN antibody blocked gp82 binding to FN, microtiter plates
coated with FN (2 g/well) were incubated with the recombinant
cruzipain gp82 (10 g/ml) in the absence or in the presence of
anti-FN antibody diluted 1:50. Binding of the recombinant gp82
to FN in the absence or in the presence of anti-FN antibody was
comparable (Fig. 5C). An additional experiment consisted of in-
cubating MT for 1 h in DMEM-FBS in the absence or in the pres-
FIG 4 Involvement of T. cruzi cruzipain in host cell invasion. (A) Metacyclic
forms (CL strain) were treated for 15 min with the cysteine proteinase inhib-
itor Z-(S-Bzl)Cys-Phe-CNH2 at 10 M and then incubated for 1 h with HeLa
cells. Values are the means  SD from five experiments performed in tripli-
cate. Treatment with the inhibitor significantly reduced MT invasion (*, P
0.0005). (B) HeLa cells cultured in DMEM-FBS were treated with 170 nM
recombinant cruzipain for 1 h at 37°C. After washing in PBS, the untreated and
cruzipain-treated cells were incubated withMT for 1 h in serum-free DMEM-
BSA medium. Values are the means SD from three experiments performed
in triplicate. Treatment with cruzipain significantly increased the HeLa cell
susceptibility to MT invasion (*, P  0.005). (C) HeLa cells, untreated or
treatedwith recombinant cruzipain as described for panel B, were incubated in
DMEM-BSA medium with MT pretreated with anti-gp82 monoclonal anti-
body or left untreated. Values are themeans SD from three assays performed
in duplicate. Anti-gp82 antibody significantly inhibited the MT invasion of
untreated or cruzipain-treated HeLa cells (*, P 0.05).
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ence of anti-FN antibody generated in rabbit, followed by process-
ing for FACS analysis. As shown in Fig. 5D, there was a small
increase in FN association with parasites in the presence of
anti-FN antibody.
DISCUSSION
Among the diverse host molecules that T. cruzi encounters before
reaching the target cells are the extracellular matrix components,
such as fibronectin, laminin, and collagen, whichmay either facil-
itate or function as a barrier for parasite migration or interaction
with the target cell. Our study using CL strain metacyclic forms
has indicated that the parasites do not require FN for target HeLa
cell invasion; rather, FN may hinder MT interaction with host
cells. The amount of FN from serum present in cell cultures does
not preclude MT invasion, because the parasite cruzipain activity
is capable of digesting FN. However, the presence of FN at con-
centrations higher than those of T. cruzi cysteine protease can
properly degrade impairs the parasite internalization. Cruzipain
has been implicated in host cell entry of TCT through a mecha-
nism that involves the action on the cell-bound kininogen and
generation of bradykinin that, upon recognition by the B2 type of
bradykinin receptor, triggers the Ca2 mobilization required for
parasite internalization (35). There is no report on FN-digesting
activity of TCT cruzipain associated with enhanced TCT invasion
capacity.What has been reported is that an 80-kDa enzyme, which
is amember of the prolyl oligopeptidase family of serine proteases
with specificity for human collagen types I and IV and is found in
cell extracts of trypomastigotes, amastigotes, and epimastigotes
(16, 38), also hydrolyzes FN, and irreversible inhibitors of that
enzyme block TCT entry into nonphagocytic mammalian cells
(38, 39).
Studies by several authors, working with blood trypomastig-
otes or with TCT, have shown that FN enhances the association of
parasites with host cells. In addition to the findings that treatment
FIG 5 Effect of anti-FN antibody onT. cruzi entry into host cells and on the FN-degrading activity of cruzipain. (A)HeLa cells were left untreated or were treated
for 15min with anti-FN or anti-1 integrin antibody and diluted 1:100, and thenmetacyclic forms (CL strain) were added. After 1 h of incubation, the cells were
processed for Giemsa staining for intracellular parasite counting. Values are the means SD from four experiments performed in duplicate. Anti-FN antibody
exhibited a significant inhibitory effect onMT invasion (*, P 0.0005). (B) Metacyclic forms (CL strain) were incubated for 1 h with 2 g FN in the absence or
presence of anti-FN antibody. Following centrifugation, the supernatant was collected and analyzed by immunoblotting using anti-FN antibody. (C) The
recombinant gp82 protein was added to microtiter plates coated with FN and incubated for 1 h in the absence or presence of anti-FN antibody. Values are the
means SD from three assays performed in triplicate. (D)Metacyclic formswere incubated for 1 h inDMEM-FBS in the absence or presence of anti-FN antibody
generated in rabbits and processed for FACS analysis using anti-FN antibody raised in mice. The control refers to parasites that were incubated only with
secondary anti-Alexa Fluor 488-conjugated anti-mouse IgG. Parasites that were incubated with monoclonal antibody 3F6 directed to gp82 also are shown.
Maeda et al.
5172 iai.asm.org Infection and Immunity
of eithermouse peritonealmacrophages or blood trypomastigotes
with human plasma FN increased parasite internalization (40),
there are reports that nonphagocytic cells, such as cardiomyocytes
and fibroblasts, have their associationwith TCT augmented by FN
(7, 41). Based on these observations, it has been suggested that FN
bridges parasite-target cell association, leading to enhanced infec-
tion. FN also would bridge the interaction of amastigotes with
host cells. The addition of exogenous FN, at 200 g/ml, was re-
ported to increase the uptake of amastigotes bymacrophages (10).
In our experiments, a 10-fold lower FN concentration was inhib-
itory for MT invasion of HeLa cells. The observations that TCT
and amastigotes use FN as a bridge to interact with target cells are
similar to those described for the invasion of bacteria such as S.
aureus. Through the FN-binding protein that functions as an in-
vasin, S. aureus interacts with integrin 51 through FN-depen-
dent bridging to this host cell receptor (3). A similar mode of
interaction may occur in the uptake of TCT by human macro-
phages, which was blocked by monoclonal antibodies specific for
the 1 subunit of the VLA integrin family, with this inhibition
correlating with their respective ability to block FN binding to
macrophages (42). Different from the finding that antibodies to
1 integrins inhibit S. aureus or TCT entry into target cells, by
blocking the formation of FN bridge (2, 42), antibodies to 1
integrins failed to inhibit T. cruzi MT internalization, consistent
with the fact that the cell invasion process in this case is FN inde-
pendent.
MT surface molecule gp82 binds to FN. As gp82 interacts with
the host cell receptor and triggers the activation of signaling cas-
cades that lead to Ca2-mediated actin cytoskeleton disruption
and lysosome exocytosis, events that facilitate MT invasion (26,
43), gp82-mediated binding to FN would hamper parasite-host
cell interaction. FN may protect host epithelial cells from being
invaded by MT if gp82 remains bound to it, but this protective
effect can be overcome by the FN-degrading activity of cruzipain.
Unlike FN-dependent S. aureus entry into bovine mammary
gland epithelial cell lines, which relies on the host cell signaling
system associated with protein tyrosine kinase (PTK) activation
and is reduced by 95% by the PTK inhibitor genistein (1), the
gp82-dependent T. cruzi MT invasion does not require PTK acti-
vation (44), it requires the activation of target cell signaling path-
ways that involve the participation of protein kinase C, mamma-
lian target of rapamycin (mTOR), and phosphatidylinositol
3-kinase (43). We have previously found that gp82 binding to
target cells is not mediated by extracellular matrix components,
such as collagen, laminin, and heparan sulfate (11, 14).
The FN-degrading activity of cruzipainmay play an important
role in host cell invasion by metacyclic forms of T. cruzi strains
that rely on the gp82 molecule to enter target cells. Experiments
with metacyclic forms of T. cruzi strain Y82, which also engage
gp82 to invade host cells (45), revealed that FN inhibits parasite
entry into host cells when present at concentrations higher than
the cruzipain activity can fully digest, and that treatment of target
cells with the recombinant cruzipain increases parasite internal-
ization, whereas the cysteine proteinase inhibitor has the opposite
effect (data not shown). Unlike CL and Y82 strains, G strain me-
tacyclic forms, which are less invasive toward human epithelial
cells, lacked cruzipain activity. In G strain, cruzipain is bound to
its natural inhibitor, chagasin (36), so that its contribution to the
infection process probably is null or negligible. Even secreted cha-
gasin is bound to cruzipain, which would preclude, for instance,
its potential inhibitory activity on host cysteine proteinases (36).
Apparently, under full nutrient conditions in serum-containing
medium, G strain MT enter target cells in a gp82-independent
manner (46), compatible with the observation that they are un-
able to degrade FN and release FN-bound gp82 for interaction
with its receptor.
Taken together, the results described here indicate that the
gp82-mediated internalization of T. cruzi metacyclic forms does
not require an extracellular matrix component to bridge the in-
teraction with the host cell receptor.
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